Stock Market News5 days SNY and REGN’s Dupixent sBLA for Skin Disease Gets FDA’s Priority Tag Zacks
The FDA is set to give its decision on SNY and REGN’s sBLA for Dupixent for bullous pemphigoid by June 20, 2025.
XThe FDA is set to give its decision on SNY and REGN’s sBLA for Dupixent for bullous pemphigoid by June 20, 2025.
X